Pfizer says anti-COVID pill effective in large trial

Pfizer says that clinical trials confirm its anti-COVID pill reduced hospitalizations and deaths among at-risk people by almost 90 percent when it was taken in the first few days after symptoms appear.

The results are based on trials of more than 2,200 people and back up findings announced last month from preliminary trials. The drug maker also said the treatment appears to be effective against the Omicron variant.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.